Genomma Lab Internacional, SAB de CV (BMV: LABB), a pharmaceutical and personal care product company in Mexico, announced on Friday its cash dividend.
The company has declared a cash dividend of MXN0.196080 per share on its common stock, representing a total amount of MXN200,001,600.00.
The dividend will be paid to shareholders of record at 7 June 2023. The amount is based on the total LABB shares presently in circulation.
(USD1=MXN17.56)
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government